Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100
BASEL, Switzerland, April 16, 2026 (GLOBE NEWSWIRE) -- BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated...
-
Austin, TX, USA, April 16, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Vacuum Skin Packaging Market Size, Trends and Insights By Type (Flat Skin...
-
Tivoxavir marboxil advancing towards a human influenza challenge trial as a once-monthly prophylactic agent, building on broad preclinical antiviral activity, Ratutrelvir topline Phase 2a data show...
-
Austin, TX, USA, April 15, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Collation Shrink Films Market Size, Trends and Insights By Product Type...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Tomato Processing Market Report by Product Type, Distribution Channel, and Region 2026-2034" has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "GMP Principles in Vaccine Manufacturing (June 16th - June 17th, 2026)" training has been added to ResearchAndMarkets.com's offering.In this two-day...
-
Financing led by Sirenia Capital Management LP advances Traws Pharma's influenza program through a human challenge trial for tivoxavir marboxil in the United Kingdom NEWTOWN, Pa., April 15, 2026 ...
-
Fast Track designation has the potential to facilitate development and accelerate FDA review of imdusiran WARMINSTER, Pa., April 15, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:...
-
VIRGINIA CITY, Nev., April 15, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE American: LODE) (“Comstock” and the “Company”) today announced that its chief executive officer issued the following...
-
Rapid diagnostic tests market grows with rising infections, home testing adoption, driven by tech advances, fast results, and expanding healthcare access.